Position in HLN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$710,216
+$65,193 QoQ
Shares Held
76,122
+18.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#165
of 639 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Ascent Group, LLC holds $3,280,030 across 8 Drug Manufacturers - Specialty & Generic names. HLN ranks #2 (21.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
10,866 | $780,830 | |
| 2 | HLN |
Haleon plc
This page
|
76,122 | $710,216 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,220 | $661,032 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
4,101 | $454,964 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
16,734 | $268,244 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
3,273 | $209,307 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
10,828 | $156,897 | |
| 8 | ALVO |
Alvotech
|
10,445 | $38,540 |
All Filings in HLN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $710,216 | 76,122 | Shares | Other | 2026-08-03 | |
| 2026-03-31 | $645,023 | 64,438 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $661,981 | 65,478 | Shares | Other | 2026-01-20 | |
| 2025-09-30 | $297,961 | 33,218 | Shares | Other | 2025-10-20 | |
| 2025-06-30 | $1,380,173 | 133,093 | Shares | Other | 2025-07-21 | |
| 2025-03-31 | $568,706 | 55,268 | Shares | Other | 2025-05-16 | |
| No filing history on record for this holder in this stock. | ||||||